Castellan Group’s CVS Health CVS Stock Holding History

Castellan Group’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-41,600	Closed	-$3.53M	–	77
2021 Q3	$3.53M	Sell	41,600 -150,000	-78%	-$12.6M	1.82%	10
2021 Q2	$16M	Hold	191,600	–	–	6.71%	3
2021 Q1	$14.4M	Buy	+191,600	New	+$14M	7.7%	1

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Castellan Group's CVS Position: Q4 2021 in Review

Castellan Group sold out of CVS Health (CVS) in Q4 2021, closing a stake of 41,600 shares — an estimated $3.53M sold.

Castellan Group first reported a position in CVS in Q1 2021 and held it in 3 quarters. The position peaked at $16M in Q2 2021. 2,342 funds tracked by Wall St. Rank hold CVS as of Q4 2021.

Castellan Group reported no remaining CVS Health position as of Q4 2021 after selling out during the quarter.
Castellan Group sold 41,600 CVS Health shares in Q4 2021, an estimated $3.53M.
Castellan Group first reported a position in CVS Health in Q1 2021 and held it in 3 quarters.
Castellan Group's CVS Health position peaked at $16M in Q2 2021.
2,342 funds tracked by Wall St. Rank held CVS Health as of Q4 2021.

Based on Castellan Group's 13F filing for Q4 2021, filed 16 Feb 2022.